LegisTrack
Back to all bills
S 2770119th CongressIntroduced

Share the Savings with Seniors Act

Introduced: Sep 11, 2025
HealthcareSocial Services
Standard Summary
Comprehensive overview in 1-2 paragraphs

Share the Savings with Seniors Act would change how Medicare Part D determines cost-sharing for chronic care drugs. Starting with plan years beginning on or after January 1, 2027, the bill would require that cost-sharing for chronic care drugs be tied to the drug’s net price (the negotiated price after manufacturer concessions not reflected in the negotiated price), rather than to list prices or other benchmarks. For costs below the annual deductible, cost-sharing cannot exceed the net price. For costs above the deductible and below the plan’s out-of-pocket threshold, coinsurance would generally be based on a percentage of the net price, with an exception if a plan uses a fixed copayment not tied to a percentage of price or to price benchmarks. The bill also defines which drugs count as “chronic care drugs” using USP categories, ensures coverage is guided by these rules, and applies protections for low-income beneficiaries to prevent excessive copayments. Regulators would implement these changes via interim final regulations. In short, the act aims to reduce or cap out-of-pocket costs for chronic care medications by anchoring cost-sharing to the net price and limiting high coinsurance, beginning in 2027, while preserving some plan design flexibility and protecting low-income enrollees.

Key Points

  • 1Establishes cost-sharing for chronic care drugs (under Medicare Part D) based on net price, with specific rules for costs below the deductible and between the deductible and out-of-pocket threshold starting plan years after 2026.
  • 2For amounts above the deductible, coinsurance must generally be a percentage of the net price, unless a plan uses a fixed copayment not tied to a percentage or to price benchmarks.
  • 3Defines “chronic care drug” via USP categories/classes (per USP Medicare Model Guidelines) and includes a net price definition for calculating cost-sharing.
  • 4Adds a rule that the coverage for chronic care drugs follows the new cost-sharing framework (subsection (c)(7)).
  • 5Includes a conforming protection for low-income enrollees: copayments for chronic drugs in 2027+ cannot exceed the applicable cost-sharing for the drug under the person’s prescription drug plan or MA-PD plan.
  • 6Directs the Secretary of Health and Human Services to implement these changes via interim final regulations, allowing quicker initial implementation.

Impact Areas

Primary group/area affected: Medicare Part D beneficiaries, especially seniors and individuals with chronic diseases who rely on chronic care medications; impact depends on plan design and net-price calculations.Secondary group/area affected: Plan sponsors, pharmaceutical manufacturers, and Pharmacy Benefit Managers (PBMs) who negotiate prices and structure cost-sharing; potential shifts in formulary negotiation and rebates to align with the new net-price-based framework.Additional impacts:- Low-income subsidy recipients would see protections to prevent excessive copayments for chronic drugs.- Plan designs may adjust to maintain actuarial soundness or cost-sharing structures given the net-price approach.- Regulatory burden rises due to interim final regulations and the need for clear guidance on calculating net price and identifying chronic care drugs.- Administrative complexity for determining net price and applying the new rules across diverse drugs and plans.
Generated by gpt-5-nano on Oct 2, 2025